Health Catalyst

Forecast & Rating7 analysts currently cover Health Catalyst, with about 28.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $2.25, about 7.7% upside from the current price of $2.09. Price targets range from $1.75 to $3.00 — a wide spread, showing clear disagreement over just how much Health Catalyst can rise. Historically, about 16.9% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Health Catalyst's outlook. Data as of Jul 23, 2026; for reference only and not investment advice.